Ooi Keong (OK) LEE

Speaking Topics

What It Takes To Be Investable

Sales, Marketing and Customer Experience

Synopsis

Most boards believe strong strategy, risk frameworks, and performance targets are sufficient to attract capital. Institutional investors evaluate something deeper: decision quality under stress, capital discipline across cycles, downside resilience, and credibility when it matters most. Drawing from 16 years evaluating over 300 companies and transactions at Temasek, and serving as a Board Director and Investment Risk Leader, Ooi Keong Lee reveals how capital actually thinks. The session uncovers why well intentioned board decisions sometimes destroy value, and how to close the gap between corporate intent and investor expectations. Participants learn how to redesign strategy, enterprise risk management, and investor relations through a decision centric lens that builds sustainable confidence, valuation support, and long term institutional backing.

Target Audience

CEOs, CFOs, and Heads of Strategy, Risk, or Investor Relations

Key Benefits

Participants gain the institutional investor lens and practical frameworks to enhance decision quality and long term investability.

Outline

Strategic Move 1 Strengthen board strategy using institutional capital discipline lens Understand how institutional investors assess strategy beyond narrative ambition. Participants learn how the PRICE framework aligns board level decisions with what investors actually reward, strengthening credibility and valuation resilience. Strategic Move 2 Redesign enterprise risk management into performance driver system Explore why compliance driven risk fails during volatility. Participants learn how to transform risk management into a decision centric system that anticipates geopolitical and macroeconomic shocks before they escalate. Strategic Move 3 Elevate investment decision quality through independent stress testing Discover the institutional playbook that delivered 180 to 220 basis points of systematic outperformance. Participants learn debiasing protocols, independent review processes, and margin of safety principles that improve capital allocation outcomes.

No bio available.